FOR IMMEDIATE RELEASE
|
23 OCTOBER 2015
|
BOARD CHANGE
ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, announces that Ajay Agrawal has stepped down as Non-Executive Director with immediate effect.
Tim McCarthy, Non-Executive Chairman said: "We would like to thank Ajay for his contribution whilst at ImmuPharma.
"In the short period of time as Chairman, I have become more convinced of our lead programme Lupuzor. This has the potential to bring success for ImmuPharma, reward our long standing shareholders and ultimately to provide a significant treatment for lupus sufferers, globally. I am delighted to be part of the team driving this strategy forward."
-Ends-
For further information please contact:
ImmuPharma plc
|
+ 44 (0) 20 7152 4080
|
Tim McCarthy, Chairman
|
|
Lisa Baderoon, Head of Investor Relations
|
+ 44 (0) 7721 413496
|
|
|
Panmure, Gordon & Co., NOMAD & Broker
|
+44 (0) 20 7886 2500
|
Fred Walsh, Duncan Monteith, Corporate Finance
Charles Leigh-Pemberton, Corporate Broking
|
|
|
|
|
|
|
|
|
|